Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-16
2006-05-16
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S414000, C514S339000, C514S363000, C514S365000, C548S492000, C548S465000, C548S181000, C548S139000, C546S278100
Reexamination Certificate
active
07045544
ABSTRACT:
The invention relates to compounds of formula (I), to a method for the production thereof, and to the use of the same as pharmaceuticals for the treatment of diseases in humans and/or animals
REFERENCES:
patent: 6337344 (2002-01-01), Defossa et al.
patent: 0563475 (1993-06-01), None
patent: 9933800 (1999-08-01), None
patent: 9732874 (1997-12-01), None
patent: 9414434 (1994-07-01), None
patent: WO 9933800 (1998-07-01), None
patent: 9852925 (1998-11-01), None
Brands Michael
Ergüden Jens-Kerim
Krahn Thomas
Schröder Christian
Stasch Johannes-Peter
Bayer HealthCare AG
Freistein Andrew
Shameem Golam M. M.
LandOfFree
Substituted 2,5-diamidoindoles as ECE inhibitors for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2,5-diamidoindoles as ECE inhibitors for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2,5-diamidoindoles as ECE inhibitors for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3629144